GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) » Definitions » Cash Flow from Investing

Extrawell Pharmaceutical Holdings (HKSE:00858) Cash Flow from Investing : HK$-6.75 Mil (TTM As of Sep. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Extrawell Pharmaceutical Holdings Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Sep. 2023, Extrawell Pharmaceutical Holdings spent HK$0.00 Mil on purchasing property, plant, equipment. It gained HK$0.00 Mil from selling property, plant, and equipment. It spent HK$0.00 Mil on purchasing business. It gained HK$0.00 Mil from selling business. It spent HK$0.00 Mil on purchasing investments. It gained HK$0.00 Mil from selling investments. It paid HK$0.00Mil for net Intangibles purchase and sale. And it paid HK$0.00 Mil for other investing activities. In all, Extrawell Pharmaceutical Holdings spent HK$4.43 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Sep. 2023.


Extrawell Pharmaceutical Holdings Cash Flow from Investing Historical Data

The historical data trend for Extrawell Pharmaceutical Holdings's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Extrawell Pharmaceutical Holdings Cash Flow from Investing Chart

Extrawell Pharmaceutical Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.11 -7.30 -0.04 -9.38 -8.44

Extrawell Pharmaceutical Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -9.13 -6.12 -2.32 -4.43

Extrawell Pharmaceutical Holdings Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Extrawell Pharmaceutical Holdings's Cash Flow from Investing for the fiscal year that ended in Mar. 2023 is calculated as:

Extrawell Pharmaceutical Holdings's Cash Flow from Investing for the quarter that ended in Sep. 2023 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-6.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Extrawell Pharmaceutical Holdings  (HKSE:00858) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Extrawell Pharmaceutical Holdings's purchase of property, plant, equipment for the six months ended in Sep. 2023 was HK$0.00 Mil. It means Extrawell Pharmaceutical Holdings spent HK$0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Extrawell Pharmaceutical Holdings's sale of property, plant, equipment for the six months ended in Sep. 2023 was HK$0.00 Mil. It means Extrawell Pharmaceutical Holdings gained HK$0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Extrawell Pharmaceutical Holdings's purchase of business for the six months ended in Sep. 2023 was HK$0.00 Mil. It means Extrawell Pharmaceutical Holdings spent HK$0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Extrawell Pharmaceutical Holdings's sale of business for the six months ended in Sep. 2023 was HK$0.00 Mil. It means Extrawell Pharmaceutical Holdings gained HK$0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Extrawell Pharmaceutical Holdings's purchase of investment for the six months ended in Sep. 2023 was HK$0.00 Mil. It means Extrawell Pharmaceutical Holdings spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Extrawell Pharmaceutical Holdings's sale of investment for the six months ended in Sep. 2023 was HK$0.00 Mil. It means Extrawell Pharmaceutical Holdings gained HK$0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Extrawell Pharmaceutical Holdings's net Intangibles purchase and sale for the six months ended in Sep. 2023 was HK$0.00 Mil. It means Extrawell Pharmaceutical Holdings paid HK$0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Extrawell Pharmaceutical Holdings's cash from discontinued investing activities for the six months ended in Sep. 2023 was 0.00 Mil. It means Extrawell Pharmaceutical Holdings paid HK$0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Extrawell Pharmaceutical Holdings's cash from other investing activities for the six months ended in Sep. 2023 was HK$0.00 Mil. It means Extrawell Pharmaceutical Holdings paid HK$0.00 Mil for other investing activities.


Extrawell Pharmaceutical Holdings Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Extrawell Pharmaceutical Holdings's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Extrawell Pharmaceutical Holdings (HKSE:00858) Business Description

Traded in Other Exchanges
N/A
Address
979 King’s Road, Suites 2206-08, 22nd Floor, Devon House, Taikoo Place, Quarry Bay, Hong Kong, HKG
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing; Trading and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. The gene development segment is engaged in the commercial exploitation and development of genome-related technology. Geographically, it derives a majority of its revenue from China.
Executives
Mao Yumin 2201 Interest of corporation controlled by you
Biowindow Gene Development (hong Kong) Limited 2201 Interest of corporation controlled by you
Ease Gold Investments Limited 2201 Interest of corporation controlled by you
Jnj Investments Ltd 2201 Interest of corporation controlled by you
United Gene Group Ltd 2201 Interest of corporation controlled by you
United Gene Holdings Limited 2201 Interest of corporation controlled by you
United Gene International Holdings Group Limited 2101 Beneficial owner
Xie Yi 2201 Interest of corporation controlled by you
Huang Zhenping 2101 Beneficial owner
United Gene Industry Group Limited 2101 Beneficial owner
Chen Xuhua 2202 Interest of your spouse
Cheng Yong 2201 Interest of corporation controlled by you

Extrawell Pharmaceutical Holdings (HKSE:00858) Headlines

No Headlines